Literature DB >> 8001945

Surveillance report: disease trends at New Zealand sexually transmitted disease clinics 1977-1993.

P H Lyttle1.   

Abstract

AIM: To document trends in sexually transmitted diseases (STDs) recorded by New Zealand STD Clinics from 1977-1993.
METHODS: Clinic disease figures have been recorded since clinics commenced in the 1920s and were recorded in a comprehensive format from the 1970s. The New Zealand Venereological Society has collated these data since 1986.
RESULTS: The most common STDs in New Zealand clinics are genital warts, non-specific genital infections, chlamydia and genital herpes. Genital Wart infection has been the commonest STD diagnosed in clinics since 1988 and occurred in 17.9% of new patients in 1993. Non Specific Genital Infections were the commonest diagnosis from 1977 to 1988 affecting 17.5% of new patients in 1993. Chlamydia has shown a fall since the mid 1980s diagnosed in 5.4% of new patients in 1993 compared with 14.6% in 1986. Gonorrhoea incidence has fallen steadily since 1975 affecting only 1.1% new patients in 1993. Genital Herpes numbers tripled from 1977 to 1993 and 54% are primary cases. HIV Disease has increased clinic workload greatly with screening and counselling conducted in 25% of new patients in 1993. HIV disease was diagnosed or managed in 0.2% new clinic patients (49 cases). Syphilis has remained at a low incidence in New Zealand diagnosed in 0.3% new patients in 1993.
CONCLUSION: Attendance for the viral diseases, HIV disease, genital warts and genital herpes is increasing while for the bacterial diseases, gonorrhoea and chlamydia is decreasing. The rise in disease numbers since 1990 may be due to meeting service needs rather than a true rise in disease incidence. STD surveillance in New Zealand is improving with new reporting systems being developed.

Entities:  

Mesh:

Year:  1994        PMID: 8001945      PMCID: PMC1195277          DOI: 10.1136/sti.70.5.329

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  12 in total

1.  The changing face of sexually transmitted disease.

Authors:  W M Platts
Journal:  N Z Med J       Date:  1979-09-26

2.  Sexually transmitted diseases in the 1990s.

Authors:  W Cates; A R Hinman
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

3.  Genital herpes trends.

Authors:  P H Lyttle
Journal:  N Z Med J       Date:  1988-12-14

4.  Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases.

Authors:  T C Quinn; D Glasser; R O Cannon; D L Matuszak; R W Dunning; R L Kline; C H Campbell; E Israel; A S Fauci; E W Hook
Journal:  N Engl J Med       Date:  1988-01-28       Impact factor: 91.245

5.  The prevalence of sexually transmitted disease agents in pregnant women in Suva.

Authors:  R Gyaneshwar; H Nsanze; K P Singh; S Pillay; I Seruvatu
Journal:  Aust N Z J Obstet Gynaecol       Date:  1987-08       Impact factor: 2.100

6.  Sexually transmitted disease seen in general practice in Northland: a survey.

Authors:  R J Flight
Journal:  N Z Med J       Date:  1982-04-14

7.  A survey of virus infections in New Zealand, 1982-6.

Authors:  R C Lau; A E Smith; R Cursons; M I Tobias; P Shult; E S Poole
Journal:  N Z Med J       Date:  1988-10-12

8.  Hepatitis B serology in 1000 VD clinic attenders.

Authors:  J L Faoagali
Journal:  N Z Med J       Date:  1981-10-28

9.  The virus of hepatitis B a new dimension in the diagnosis of sexually transmitted disease.

Authors:  H C Stringer; E R Smith; A C Stewart
Journal:  N Z Med J       Date:  1978-01-25

10.  Trends in hepatitis B notifications 1976-87.

Authors:  D Bandaranayake; R Carlson
Journal:  N Z Med J       Date:  1990-06-27
View more
  2 in total

Review 1.  The role of epidemiology and surveillance systems in the control of sexually transmitted diseases.

Authors:  M A Catchpole
Journal:  Genitourin Med       Date:  1996-10

Review 2.  Vaccines against genital herpes: progress and limitations.

Authors:  Lynda A Morrison
Journal:  Drugs       Date:  2002       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.